Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study,Pediatric Diabetes

当前位置： X-MOL 学术 › Pediatr. Diabetes › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study
Pediatric Diabetes ( IF 3.4 ) Pub Date : 2021-05-12 , DOI: 10.1111/pedi.13232
Mary Ellen Vajravelu _{1,

2,

3} , Talia A Hitt _{1,

3} , Sandra Amaral _{3,

4} , Lorraine E Levitt Katz _{1,

2} , Joyce M Lee ₅ , Andrea Kelly _{1,

2}

Affiliation

Due to high rates of comorbidities and rapid progression, youth with Type 2 diabetes may benefit from early and aggressive treatment. However, until 2019, the only approved medications for this population were metformin and insulin.

中文翻译：